| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.42 | 9e-10 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-08 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |